NCT04189445 2025-10-08Futibatinib in Patients With Specific FGFR AberrationsTaiho Oncology, Inc.Phase 2 Terminated115 enrolled 19 charts
NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled